Cargando…
Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis
Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is characterized by chronic relapsing inflammation of the gastrointestinal tract. Delivery of orally administered drugs to the colon is highly desirable for the treatment of UC, as it improves their efficac...
Autores principales: | Zhang, Mingzhen, Merlin, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085987/ https://www.ncbi.nlm.nih.gov/pubmed/29788186 http://dx.doi.org/10.1093/ibd/izy123 |
Ejemplares similares
-
Refractory Complex Crohn’s Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection
por: Laureti, Silvio, et al.
Publicado: (2020) -
Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation
por: Xiao, Bo, et al.
Publicado: (2016) -
Use of Cancer Stem Cells to Investigate the Pathogenesis of Colitis-associated Cancer
por: Davies, Julie M., et al.
Publicado: (2016) -
Prophylaxis of necrotizing enterocolitis by oral IgA-IgG: Review of a clinical study in low birth weight infants and discussion of the pathogenic role of infection
por: Eibl, Martha M., et al.
Publicado: (1990) -
Metagenomic Analysis of Microbiome in Colon Tissue from Subjects with Inflammatory Bowel Diseases Reveals Interplay of Viruses and Bacteria
por: Wang, Weiwei, et al.
Publicado: (2015)